Overview

POISE Trial: Perioperative Ischemic Evaluation Study

Status:
Terminated
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the ability of metoprolol (a beta-blocker drug) to prevent heart attacks and deaths around the time of surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborators:
AstraZeneca
British Heart Foundation
Canadian Institutes of Health Research (CIHR)
National Health and Medical Research Council, Australia
Treatments:
Metoprolol